These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 23818607

  • 1. TET1 plays an essential oncogenic role in MLL-rearranged leukemia.
    Huang H, Jiang X, Li Z, Li Y, Song CX, He C, Sun M, Chen P, Gurbuxani S, Wang J, Hong GM, Elkahloun AG, Arnovitz S, Wang J, Szulwach K, Lin L, Street C, Wunderlich M, Dawlaty M, Neilly MB, Jaenisch R, Yang FC, Mulloy JC, Jin P, Liu PP, Rowley JD, Xu M, He C, Chen J.
    Proc Natl Acad Sci U S A; 2013 Jul 16; 110(29):11994-9. PubMed ID: 23818607
    [Abstract] [Full Text] [Related]

  • 2. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
    Huang H, Jiang X, Wang J, Li Y, Song CX, Chen P, Li S, Gurbuxani S, Arnovitz S, Wang Y, Weng H, Neilly MB, He C, Li Z, Chen J.
    Cancer Lett; 2016 Mar 28; 372(2):157-65. PubMed ID: 26791235
    [Abstract] [Full Text] [Related]

  • 3. PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease.
    Li Z, Chen P, Su R, Hu C, Li Y, Elkahloun AG, Zuo Z, Gurbuxani S, Arnovitz S, Weng H, Wang Y, Li S, Huang H, Neilly MB, Wang GG, Jiang X, Liu PP, Jin J, Chen J.
    Cancer Res; 2016 Feb 01; 76(3):619-29. PubMed ID: 26747896
    [Abstract] [Full Text] [Related]

  • 4. Initiation of MLL-rearranged AML is dependent on C/EBPα.
    Ohlsson E, Hasemann MS, Willer A, Lauridsen FK, Rapin N, Jendholm J, Porse BT.
    J Exp Med; 2014 Jan 13; 211(1):5-13. PubMed ID: 24367003
    [Abstract] [Full Text] [Related]

  • 5. TGIF1 is a negative regulator of MLL-rearranged acute myeloid leukemia.
    Willer A, Jakobsen JS, Ohlsson E, Rapin N, Waage J, Billing M, Bullinger L, Karlsson S, Porse BT.
    Leukemia; 2015 May 13; 29(5):1018-31. PubMed ID: 25349154
    [Abstract] [Full Text] [Related]

  • 6. MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia.
    Jiang X, Huang H, Li Z, He C, Li Y, Chen P, Gurbuxani S, Arnovitz S, Hong GM, Price C, Ren H, Kunjamma RB, Neilly MB, Salat J, Wunderlich M, Slany RK, Zhang Y, Larson RA, Le Beau MM, Mulloy JC, Rowley JD, Chen J.
    Proc Natl Acad Sci U S A; 2012 Nov 20; 109(47):19397-402. PubMed ID: 23132946
    [Abstract] [Full Text] [Related]

  • 7. Interaction of MLL amino terminal sequences with menin is required for transformation.
    Caslini C, Yang Z, El-Osta M, Milne TA, Slany RK, Hess JL.
    Cancer Res; 2007 Aug 01; 67(15):7275-83. PubMed ID: 17671196
    [Abstract] [Full Text] [Related]

  • 8. Tet1 is not required for myeloid leukemogenesis by MLL-ENL in novel mouse models.
    Ono R, Masuya M, Inoue N, Shinmei M, Ishii S, Maegawa Y, Maharjan BD, Katayama N, Nosaka T.
    PLoS One; 2021 Aug 01; 16(3):e0248425. PubMed ID: 33705482
    [Abstract] [Full Text] [Related]

  • 9. PBX3 is essential for leukemia stem cell maintenance in MLL-rearranged leukemia.
    Guo H, Chu Y, Wang L, Chen X, Chen Y, Cheng H, Zhang L, Zhou Y, Yang FC, Cheng T, Xu M, Zhang X, Zhou J, Yuan W.
    Int J Cancer; 2017 Jul 15; 141(2):324-335. PubMed ID: 28411381
    [Abstract] [Full Text] [Related]

  • 10. PBX3 is an important cofactor of HOXA9 in leukemogenesis.
    Li Z, Zhang Z, Li Y, Arnovitz S, Chen P, Huang H, Jiang X, Hong GM, Kunjamma RB, Ren H, He C, Wang CZ, Elkahloun AG, Valk PJ, Döhner K, Neilly MB, Bullinger L, Delwel R, Löwenberg B, Liu PP, Morgan R, Rowley JD, Yuan CS, Chen J.
    Blood; 2013 Feb 21; 121(8):1422-31. PubMed ID: 23264595
    [Abstract] [Full Text] [Related]

  • 11. HOXA9 is required for survival in human MLL-rearranged acute leukemias.
    Faber J, Krivtsov AV, Stubbs MC, Wright R, Davis TN, van den Heuvel-Eibrink M, Zwaan CM, Kung AL, Armstrong SA.
    Blood; 2009 Mar 12; 113(11):2375-85. PubMed ID: 19056693
    [Abstract] [Full Text] [Related]

  • 12. miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia.
    Li Z, Huang H, Chen P, He M, Li Y, Arnovitz S, Jiang X, He C, Hyjek E, Zhang J, Zhang Z, Elkahloun A, Cao D, Shen C, Wunderlich M, Wang Y, Neilly MB, Jin J, Wei M, Lu J, Valk PJM, Delwel R, Lowenberg B, Le Beau MM, Vardiman J, Mulloy JC, Zeleznik-Le NJ, Liu PP, Zhang J, Chen J.
    Nat Commun; 2012 Feb 21; 3():688. PubMed ID: 22353710
    [Abstract] [Full Text] [Related]

  • 13. Expression of HOX genes in acute leukemia cell lines with and without MLL translocations.
    Quentmeier H, Dirks WG, Macleod RA, Reinhardt J, Zaborski M, Drexler HG.
    Leuk Lymphoma; 2004 Mar 21; 45(3):567-74. PubMed ID: 15160920
    [Abstract] [Full Text] [Related]

  • 14. TRIB2 regulates the differentiation of MLL-TET1 transduced myeloid progenitor cells.
    Kim HS, Oh SH, Kim JH, Sohn WJ, Kim JY, Kim DH, Choi SU, Park KM, Ryoo ZY, Park TS, Lee S.
    J Mol Med (Berl); 2018 Nov 21; 96(11):1267-1277. PubMed ID: 30324339
    [Abstract] [Full Text] [Related]

  • 15. Tip60 activates Hoxa9 and Meis1 expression through acetylation of H2A.Z, promoting MLL-AF10 and MLL-ENL acute myeloid leukemia.
    Yamagata K, Shino M, Aikawa Y, Fujita S, Kitabayashi I.
    Leukemia; 2021 Oct 21; 35(10):2840-2853. PubMed ID: 33967269
    [Abstract] [Full Text] [Related]

  • 16. Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential.
    Wong P, Iwasaki M, Somervaille TC, So CW, Cleary ML.
    Genes Dev; 2007 Nov 01; 21(21):2762-74. PubMed ID: 17942707
    [Abstract] [Full Text] [Related]

  • 17. MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L.
    Bernt KM, Zhu N, Sinha AU, Vempati S, Faber J, Krivtsov AV, Feng Z, Punt N, Daigle A, Bullinger L, Pollock RM, Richon VM, Kung AL, Armstrong SA.
    Cancer Cell; 2011 Jul 12; 20(1):66-78. PubMed ID: 21741597
    [Abstract] [Full Text] [Related]

  • 18. Pediatric acute myeloid leukemia with NPM1 mutations is characterized by a gene expression profile with dysregulated HOX gene expression distinct from MLL-rearranged leukemias.
    Mullighan CG, Kennedy A, Zhou X, Radtke I, Phillips LA, Shurtleff SA, Downing JR.
    Leukemia; 2007 Sep 12; 21(9):2000-9. PubMed ID: 17597811
    [Abstract] [Full Text] [Related]

  • 19. Histone H2B ubiquitin ligase RNF20 is required for MLL-rearranged leukemia.
    Wang E, Kawaoka S, Yu M, Shi J, Ni T, Yang W, Zhu J, Roeder RG, Vakoc CR.
    Proc Natl Acad Sci U S A; 2013 Mar 05; 110(10):3901-6. PubMed ID: 23412334
    [Abstract] [Full Text] [Related]

  • 20. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1.
    Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L, Rao A.
    Science; 2009 May 15; 324(5929):930-5. PubMed ID: 19372391
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.